Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNewer anti-seizure medicine for focal epilepsy.Widely used, low-interaction epilepsy medicine.
Body systemBrain & NervesBrain & Nerves
Drug classAntiseizure medicinesAntiseizure medicines
SupplyPrescription onlyPrescription only
Main usesFocal seizures, Generalised tonic-clonic seizures (add-on), Status epilepticus (IV, hospital)Focal and generalised epilepsy, Status epilepticus (IV, second line), Myoclonic seizures
How it worksCalms overactive brain signals.Calms excessive electrical activity in the brain.
Starts working1–4 hours—
Half-lifeAbout 13 hours6–8 hours
Typical adult dose50 mg twice a day, increased weekly to 100–200 mg twice a day.250–500 mg twice a day, increasing to 1,000–1,500 mg twice a day.
FormsTablet, Oral solution, IV infusionTablet, Oral solution, IV infusion, Granules
Common side effectsDizziness, Headache, Nausea, Double vision, UnsteadinessSleepiness, Tiredness, Irritability, Dizziness
Serious side effectsHeart block and rhythm problems, Suicidal thoughts, Severe skin reactions (rare)Depression, aggression or suicidal thoughts, Severe skin reactions (rare)
Don't take ifSecond- or third-degree heart blockAllergy to levetiracetam; Severe kidney impairment (adjust dose)
AlcoholBest to limit. Alcohol adds to dizziness.Best to limit. Alcohol may lower the seizure threshold and add to drowsiness.
PregnancyUse with cautionLimited data; specialist advice needed.Use with cautionOne of the lower-risk epilepsy medicines in pregnancy; plan with your specialist and take high-dose folic acid.
BreastfeedingUse with cautionPasses into milk; monitor the baby.Use with cautionPasses into milk; monitor the baby.
In use since—1999
Brand namesUnited States: VimpatUnited Kingdom: VimpatIndia: Lacosam, VimpatUnited States: Keppra, SpritamUnited Kingdom: Keppra, DesitrendIndia: Levipil, Levera, Levroxa
Legal statusUnited States: Schedule V controlled substanceUnited Kingdom: Controlled drug (Schedule 5)India: Prescription only (Schedule H)United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeN03AX18N03AX14

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker